Coronary interventions
Validation of Bleeding Risk Criteria (ARC-HBR) in Patients Undergoing Percutaneous Coronary Intervention and Comparison with Contemporary Bleeding Risk Scores February 18, 2020 | 10.4244/EIJ-D-20-00052
Showing 1-5 of 5 articles
Interventions for valvular disease
Feasibility and safety of transcaval transcatheter aortic valve implantation: a multicentre European registry February 7, 2020 | 10.4244/EIJ-D-19-00797
Interventions for valvular disease
Bioprosthetic Aortic Scallop Intentional Laceration to prevent Iatrogenic Coronary Artery obstruction (BASILICA) during transcatheter aortic valve-in-valve implantation with bioprosthetic valve fracturing via the transcaval access October 19, 2018 | 10.4244/EIJ-D-18-00553
Current state of alternative access for transcatheter aortic valve implantation
September 7, 2018 | 10.4244/EIJ-D-18-00552
Interventions for valvular disease
Prognostic impact of invasive haemodynamic measurements in combination with clinical and echocardiographic characteristics on two-year clinical outcomes of patients undergoing transcatheter aortic valve implantation April 7, 2017 | 10.4244/EIJ-D-16-00790